Cargando…

Metabolism in Retinopathy of Prematurity

Retinopathy of prematurity is defined as retinal abnormalities that occur during development as a consequence of disturbed oxygen conditions and nutrient supply after preterm birth. Both neuronal maturation and retinal vascularization are impaired, leading to the compensatory but uncontrolled retina...

Descripción completa

Detalles Bibliográficos
Autores principales: Tomita, Yohei, Usui-Ouchi, Ayumi, Nilsson, Anders K., Yang, Jay, Ko, Minji, Hellström, Ann, Fu, Zhongjie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8620873/
https://www.ncbi.nlm.nih.gov/pubmed/34832995
http://dx.doi.org/10.3390/life11111119
_version_ 1784605323654332416
author Tomita, Yohei
Usui-Ouchi, Ayumi
Nilsson, Anders K.
Yang, Jay
Ko, Minji
Hellström, Ann
Fu, Zhongjie
author_facet Tomita, Yohei
Usui-Ouchi, Ayumi
Nilsson, Anders K.
Yang, Jay
Ko, Minji
Hellström, Ann
Fu, Zhongjie
author_sort Tomita, Yohei
collection PubMed
description Retinopathy of prematurity is defined as retinal abnormalities that occur during development as a consequence of disturbed oxygen conditions and nutrient supply after preterm birth. Both neuronal maturation and retinal vascularization are impaired, leading to the compensatory but uncontrolled retinal neovessel growth. Current therapeutic interventions target the hypoxia-induced neovessels but negatively impact retinal neurons and normal vessels. Emerging evidence suggests that metabolic disturbance is a significant and underexplored risk factor in the disease pathogenesis. Hyperglycemia and dyslipidemia correlate with the retinal neurovascular dysfunction in infants born prematurely. Nutritional and hormonal supplementation relieve metabolic stress and improve retinal maturation. Here we focus on the mechanisms through which metabolism is involved in preterm-birth-related retinal disorder from clinical and experimental investigations. We will review and discuss potential therapeutic targets through the restoration of metabolic responses to prevent disease development and progression.
format Online
Article
Text
id pubmed-8620873
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-86208732021-11-27 Metabolism in Retinopathy of Prematurity Tomita, Yohei Usui-Ouchi, Ayumi Nilsson, Anders K. Yang, Jay Ko, Minji Hellström, Ann Fu, Zhongjie Life (Basel) Review Retinopathy of prematurity is defined as retinal abnormalities that occur during development as a consequence of disturbed oxygen conditions and nutrient supply after preterm birth. Both neuronal maturation and retinal vascularization are impaired, leading to the compensatory but uncontrolled retinal neovessel growth. Current therapeutic interventions target the hypoxia-induced neovessels but negatively impact retinal neurons and normal vessels. Emerging evidence suggests that metabolic disturbance is a significant and underexplored risk factor in the disease pathogenesis. Hyperglycemia and dyslipidemia correlate with the retinal neurovascular dysfunction in infants born prematurely. Nutritional and hormonal supplementation relieve metabolic stress and improve retinal maturation. Here we focus on the mechanisms through which metabolism is involved in preterm-birth-related retinal disorder from clinical and experimental investigations. We will review and discuss potential therapeutic targets through the restoration of metabolic responses to prevent disease development and progression. MDPI 2021-10-21 /pmc/articles/PMC8620873/ /pubmed/34832995 http://dx.doi.org/10.3390/life11111119 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Tomita, Yohei
Usui-Ouchi, Ayumi
Nilsson, Anders K.
Yang, Jay
Ko, Minji
Hellström, Ann
Fu, Zhongjie
Metabolism in Retinopathy of Prematurity
title Metabolism in Retinopathy of Prematurity
title_full Metabolism in Retinopathy of Prematurity
title_fullStr Metabolism in Retinopathy of Prematurity
title_full_unstemmed Metabolism in Retinopathy of Prematurity
title_short Metabolism in Retinopathy of Prematurity
title_sort metabolism in retinopathy of prematurity
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8620873/
https://www.ncbi.nlm.nih.gov/pubmed/34832995
http://dx.doi.org/10.3390/life11111119
work_keys_str_mv AT tomitayohei metabolisminretinopathyofprematurity
AT usuiouchiayumi metabolisminretinopathyofprematurity
AT nilssonandersk metabolisminretinopathyofprematurity
AT yangjay metabolisminretinopathyofprematurity
AT kominji metabolisminretinopathyofprematurity
AT hellstromann metabolisminretinopathyofprematurity
AT fuzhongjie metabolisminretinopathyofprematurity